XML 35 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Cash flows from operating activities:  
Net income$ 99,884$ 105,731
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation and amortization43,28841,607
Non-cash interest expense320463
Non-cash stock compensation expense13,40811,830
Non-cash income tax expense(248)32,260
Non-cash amortization (accretion) on investments9,6606,851
Cash flows from changes in assets and liabilities, net of effects from acquisitions of businesses:  
Restricted cash(38,825)62,413
Accounts receivable, net(8,439)10,279
Other assets(751)(4,085)
Accounts payable and accrued liabilities(10,216)889
Medical claims payable and other medical liabilities(15,463)(14,085)
Other3,501126
Net cash provided by operating activities96,119254,279
Cash flows from investing activities:  
Capital expenditures(38,468)(32,201)
Acquisitions and investments in businesses, net of cash acquired(376) 
Purchase of investments(210,890)(235,420)
Maturity of investments231,093154,979
Net cash used in investing activities(18,641)(112,642)
Cash flows from financing activities:  
Payments on long-term debt and capital lease obligations (588)
Payments to acquire treasury stock(327,886)(74,427)
Proceeds from issuance of equity20,000 
Proceeds from exercise of stock options and warrants34,75523,121
Other839(1,611)
Net cash used in financing activities(272,292)(53,505)
Net increase (decrease) in cash and cash equivalents(194,814)88,132
Cash and cash equivalents at beginning of period337,179196,507
Cash and cash equivalents at end of period$ 142,365$ 284,639